🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Using aggregate data from Mendelian randomization studies, we suggested a potential causal association between obesity and cardiovascular disease as well as diabetes. These findings are published in JAMA open: jamanetwork.com/journals/jaman…

We showed that exercise stress testing can contribute to prognostic information, even in asymptomatic, low risk cohort: ajconline.org/#/article/S000…

In this investigation published earlier today in JAMA Open, we discuss the level of spin in cardiovascular trials published in high impact journals: jamanetwork.com/journals/jaman…

Our publication in Annals of Internal Medicine led by Safi discusses the lack of data behind nutritional supplements: annals.org/aim/article-ab…

Insightful editorial from legendary Dr. Topol on our recent Annals publication that discusses the appalling lack of evidence behind dietary supplements Safi U. Khan, MD, MS annals.org/aim/article-ab…

After reviewing the ESC content, I will be the first person to admit that it has far surpassed any cardiology conference in US including and specially ACC and AHA. #ESC2019

Heartiest congratulations to Eiran Gorodeski, MD, MPH for presenting the results of ViV trial as a late breaker in HFSA (I fondly recall how diligently he worked). I truly believe that virtual visits is the way in managing a subset of HF patients moving forward #ViV #HFSA2019

I have read this editorial by Dr. Krumholz several times in the last 5 years (describes the importance of being steadfast) and would suggest everyone to read it as well: ahajournals.org/doi/10.1161/CI…

All set to attend the much awaited ISCHEMIA trial #AHA #Safiukhan

Obesity may attenuate the efficacy of anti hyperlipidemics... Findings of our analysis led by Safi published earlier today.

Not so subtle VSD seen in the clinic. To close or not to close is always the question.

Very impressed with the effect size of the intervention: nejm.org/doi/full/10.10…

It only took 145 patients to show mortality difference. Disclaimer: this is VERY severe AS [mean >50 mm] nejm.org/doi/full/10.10…

nejm.org/doi/full/10.10… Not impressed with the full text of ISCHEMIA and what it adds to the literature (or the lack thereof). Hoping they will extend the follow up though:

About ISCHEMIA: 1. 35% patients were asymptomatic 2. 15% patients had no ischemia via core lab 3. Only 80% patients in the invasive arm underwent revascularization 4. A subset of recruitment sites only had access to treadmill [with no imaging]